Dr. Mark S. Roberts MD

Recommended Articles

• Pain that Requires Prompt Medical Attention

  The following are a list of different painful experiences that one must seek medical attention for:Severe headache“If headache is accompanied by a cold, it could be sinus headache”, says Sandra Fryhofer, MD, MACP, spokeswoman for the American College of Physicians. If the headache is severe and...

• Complications of Rheumatoid Arthritis

  Rheumatoid arthritis (RA) is a chronic, autoimmune, inflammatory, and systemic disease affecting the joint’s synovial lining and other connective tissues as well. It’s a disease with a fluctuating course, with periods of active disease and, alternately, remission. Unlike osteoarthritis, RA does...

• What People with Fibromyalgia Want You to Know

  Fibromyalgia is a chronic disorder that causes extensive pain, tiredness, and tenderness all over the body. The disorder affects both men and women, though females are far more probable to develop fibromyalgia.Having fibromyalgia brings constant difficulty to daily lifeFibromyalgia is a chronic...

• Study Shows Cancer Drug Can Help Treat Lupus Patients

  As technology has progressed, medical professionals have been better able to identify more of the diseases and life threatening conditions that may plague society. As these discoveries are made, whether it be through time spent on the floor of a hospital or out in the field conducting research, each...

• Selena Gomez Starts Boxing After Kidney Transplant

  In September, an important announcement from singer and actress Selena Gomez surprised and shocked her fans: she had undergone a kidney transplant to try to combat the complications from lupus. Selena's revelation is part of a special TV program conducted by the journalist Savannah Guthrie and...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...